Plus   Neg

Microsoft Bags Multi-Billion US Army Contract For HoloLens

Tech giant Microsoft Corp. (MSFT) has bagged a multibillion-dollar deal from the U.S. Army to build customized versions of its HoloLens goggles.

According to a blog post from Microsoft, the US Army will work with the software giant on the production phase of the Integrated Visual Augmentation System (IVAS) program as it moves from rapid prototyping to production and rapid fielding.

The deal, initially unveiled three years ago, is now reportedly worth as much as $21.9 billion over 10 years.

The IVAS headset, based on HoloLens and augmented by Microsoft Azure cloud services, delivers a platform that will keep Soldiers safer and make them more effective.

Microsoft technical fellow Alex Kipman in the blog post announcing the deal said the company "has worked closely with the U.S. Army over the past two years, and together we pioneered Soldier Centered Design to enable rapid prototyping for a product to provide soldiers with the tools and capabilities necessary to achieve their mission."

The agreement runs for an initial five years, with an option to add another five years.

The initial commitment includes outfitting the Army's entire Close Combat Force, more than 120,000 soldiers, Microsoft said. The contract also includes some Azure cloud services.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Guan's Mushroom Co. is recalling all cases of its 200g/7.05-ounce packages of Enoki Mushroom citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recalled Enoki is a product of China and comes in a clear plastic package with the description "Enoki Mushroom" in English, Korean and French, and Guan's logo in the front. Shares of Roche were gaining around 2 percent in Swiss trading after the drug major reported Wednesday a 3 percent rise in first-quarter sales at constant currency basis mainly driven by strong growth in Diagnostics Division. Sales, on a reported basis, edged down 1 percent mainly with significant impact from biosimilars. Looking ahead for fiscal 2021, the company continues to expect sales to grow Church & Dwight Co., Inc. is recalling select vitafusion gummy products due to isolated manufacturing issue, the U.S. Food and Drug Administration said. The recall was initiated after the company's investigation of two consumer reports identified the possible presence of a metallic mesh material in product lots manufactured in a four-day period between October 29 and November 3, 2020.
Follow RTT